 "Torrent Pharma hits record high on FIPB nod to raise FII limit")
Don't want to miss the best from Business Standard?
Shares of Torrent Pharmaceuticals were trading higher by 5% to Rs 1,358, extending its previous day’s 3% gain on the NSE, after the government has approved the company’s proposal for increasing foreign institutional investor (FII) investment limit from 13.09% to 35%.
“This would mean a total investment of about Rs 3,000 crore. This is the biggest approval announced on Wednesday by the Foreign Investment Promotion Board (FIPB) in value terms. Pharma and medical device approvals added up to Rs 4,000 crore of foreign investment,” Business Standard report suggests. CLICK HERE TO READ FULL REPORT.
The stock opened at Rs 1,343 and hit a record high of Rs 1,369 on the NSE. Till 0939 hours, a combined 173,968 shares changed hands on the counter on the NSE and BSE.
“This would mean a total investment of about Rs 3,000 crore. This is the biggest approval announced on Wednesday by the Foreign Investment Promotion Board (FIPB) in value terms. Pharma and medical device approvals added up to Rs 4,000 crore of foreign investment,” Business Standard report suggests. CLICK HERE TO READ FULL REPORT.
The stock opened at Rs 1,343 and hit a record high of Rs 1,369 on the NSE. Till 0939 hours, a combined 173,968 shares changed hands on the counter on the NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%